As a representative of medical device enterprises, Hertai's product line covers all aspects of diabetes treatment, including insulin syringes, infusion sets, blood glucose monitors, diabetes drugs and so on. As one of the leading enterprises in the medical device industry, Hertai has strong competitiveness in product quality, customer service and market expansion. The company operates steadily and has a good development prospect, which has a broad development space in the market competition of medical device plate.
Due to the unique advantages in the medical device industry, the number of diabetic patients is increasing, which provides a huge market for the development of Hetai shares. At the same time, with the aggravation of the global population aging trend, the development of medical device industry will usher in better opportunities. Therefore, investing in Hetai shares has obvious investment value. Of course, investment is risky, so we need to choose carefully and control the risks.